MustGrow Biologics CEO discusses NexusBio acquisition and future plans ICYMI [Video]

In a recent Q&A with Proactive, MustGrow Biologics Corp. (TSX-V:MGRO, OTCQB:MGROF) CEO Corey Giasson shared insights into the company’s transformative acquisition of NexusBio Ag assets from Univar Solutions. The deal brings a seasoned sales and marketing team, an established product line in the biologics and regenerative agriculture space, and a significant revenue stream that propels MustGrow from pre-revenue status.

Giasson highlighted the strategic synergies between the two entities, plans for market expansion into the U.S., and a roadmap for 2025 that includes integrating NexusBio, growing proprietary product sales, and strengthening global partnerships. This milestone positions MustGrow for accelerated growth and deeper market penetration in the agricultural sector.

Proactive: You’ve wrapped up the acquisition of NexusBio. Can you tell us more about what you’ve acquired?

Corey Giasson: We’re excited to announce the acquisition of NexusBio Ag assets from Univar Solutions. This is a significant milestone for us. NexusBio comes with a sales and marketing team and an existing product line currently …